SourceBio International PLC Director/PDMR Shareholding (0352T)
19 Noviembre 2021 - 11:42AM
UK Regulatory
TIDMSBI
RNS Number : 0352T
SourceBio International PLC
19 November 2021
19 November 2021
SourceBio International plc
(" SourceBio", the "Company" or the "Group")
Director/PDMR Shareholding
SourceBio International plc ("the Company") has been notified
that on 18 November 2021, Harwood Capital LLP transferred in
aggregate 14,212 ordinary shares of 0.15 pence each in the Company
("Ordinary Shares") to the Limited Partners of Harwood Private
Equity IV L.P. ("HPE4") in order to satisfy distributions, in the
normal course of business. Christopher Mills, Non-Executive
Director of the Company is Chief Executive of Harwood Capital
LLP.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Harwood Capital LLP as investment
manager
--------------------------------------- -------------------------------------------
2 Reason for the notification
------------------------------------------------------------------------------------
a) Position/status Christopher Mills is a non-executive
director of the issuer and Chief
Executive of the investment manager
--------------------------------------- -------------------------------------------
b) Initial notification Initial Notification
/Amendment
--------------------------------------- -------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
------------------------------------------------------------------------------------
a) Name SourceBio International Plc
--------------------------------------- -------------------------------------------
b) LEI 213800KY4C9WU7WBW518
--------------------------------------- -------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
------------------------------------------------------------------------------------
a) Description of the Ordinary shares of GBP0.0015 each
financial instrument,
type of instrument
Identification code GB00BKSB1674
b) Nature of the transaction Transfer of shares
--------------------------------------- -------------------------------------------
c) Price(s) and volume(s)
------------------- -------------------
Price(s) Volume(s)
------------------- -------------------
Nil 14,212
---------------------------------------------------------------- -------------------
d) Aggregated information
Volume 14,212
Price Nil
e) Date of the transaction 18 November 2021
f) Place of the transaction Off market
--------------------------------------- -------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHFLFSDLILALIL
(END) Dow Jones Newswires
November 19, 2021 12:42 ET (17:42 GMT)
Sourcebio (LSE:SBI)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Sourcebio (LSE:SBI)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024
